RU2001102491A - PHARMACEUTICAL SUSPENSION DRUG CONTAINING AMOXICILLINE, CLAVANIC ACID AND CELLULOSE - Google Patents
PHARMACEUTICAL SUSPENSION DRUG CONTAINING AMOXICILLINE, CLAVANIC ACID AND CELLULOSEInfo
- Publication number
- RU2001102491A RU2001102491A RU2001102491/14A RU2001102491A RU2001102491A RU 2001102491 A RU2001102491 A RU 2001102491A RU 2001102491/14 A RU2001102491/14 A RU 2001102491/14A RU 2001102491 A RU2001102491 A RU 2001102491A RU 2001102491 A RU2001102491 A RU 2001102491A
- Authority
- RU
- Russia
- Prior art keywords
- cellulose
- paragraphs
- drug according
- preparation
- active ingredients
- Prior art date
Links
- 239000003814 drug Substances 0.000 title claims 8
- 229940079593 drugs Drugs 0.000 title claims 8
- 239000001913 cellulose Substances 0.000 title claims 5
- 229920002678 cellulose Polymers 0.000 title claims 4
- 239000002253 acid Substances 0.000 title 1
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 title 1
- 239000007971 pharmaceutical suspension Substances 0.000 title 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims 3
- 239000004480 active ingredient Substances 0.000 claims 3
- 235000010980 cellulose Nutrition 0.000 claims 3
- 239000008108 microcrystalline cellulose Substances 0.000 claims 3
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims 3
- 229940016286 microcrystalline cellulose Drugs 0.000 claims 3
- 239000002245 particle Substances 0.000 claims 2
- 229960004920 Amoxicillin Trihydrate Drugs 0.000 claims 1
- 206010060945 Bacterial infection Diseases 0.000 claims 1
- HZZVJAQRINQKSD-PBFISZAISA-N Clavulanic acid Chemical compound OC(=O)[C@H]1C(=C/CO)/O[C@@H]2CC(=O)N21 HZZVJAQRINQKSD-PBFISZAISA-N 0.000 claims 1
- 230000001058 adult Effects 0.000 claims 1
- MQXQVCLAUDMCEF-CWLIKTDRSA-N amoxicillin trihydrate Chemical compound O.O.O.C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 MQXQVCLAUDMCEF-CWLIKTDRSA-N 0.000 claims 1
- 239000007900 aqueous suspension Substances 0.000 claims 1
- 239000006172 buffering agent Substances 0.000 claims 1
- 239000006185 dispersion Substances 0.000 claims 1
- 239000000945 filler Substances 0.000 claims 1
- 239000000796 flavoring agent Substances 0.000 claims 1
- 235000013355 food flavoring agent Nutrition 0.000 claims 1
- 235000003599 food sweetener Nutrition 0.000 claims 1
- 230000002475 laxative Effects 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 239000000546 pharmaceutic aid Substances 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 235000019814 powdered cellulose Nutrition 0.000 claims 1
- 229920003124 powdered cellulose Polymers 0.000 claims 1
- 239000003381 stabilizer Substances 0.000 claims 1
- 239000003765 sweetening agent Substances 0.000 claims 1
- 239000004034 viscosity adjusting agent Substances 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Claims (9)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9815532.8 | 1998-07-17 | ||
GBGB9815532.8A GB9815532D0 (en) | 1998-07-17 | 1998-07-17 | Pharmaceutical suspension formulation |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2001102491A true RU2001102491A (en) | 2002-11-27 |
RU2205639C2 RU2205639C2 (en) | 2003-06-10 |
Family
ID=10835666
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2001102491/14A RU2205639C2 (en) | 1998-07-17 | 1999-07-15 | Pharmaceutical suspension preparation containing amoxicillin, clavulanic acid and cellulose |
Country Status (14)
Country | Link |
---|---|
US (1) | US6511972B1 (en) |
EP (1) | EP1098633A1 (en) |
AU (1) | AU762840B2 (en) |
CZ (1) | CZ296003B6 (en) |
GB (1) | GB9815532D0 (en) |
HR (1) | HRPK20010048B1 (en) |
HU (1) | HUP0103015A3 (en) |
PL (1) | PL194393B1 (en) |
RU (1) | RU2205639C2 (en) |
SK (1) | SK286339B6 (en) |
UA (1) | UA73720C2 (en) |
WO (1) | WO2000003695A1 (en) |
YU (1) | YU3101A (en) |
ZA (1) | ZA200100463B (en) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69617036T2 (en) | 1995-09-07 | 2002-07-11 | Smithkline Beecham Corp., King Of Prussia | USE OF A PEDIATRIC PHARMACEUTICAL FORMULATION CONTAINING AMOXICILLIN AND CLAVULANATE |
US7250176B1 (en) * | 1999-04-13 | 2007-07-31 | Beecham Pharmaceuticals (Pte) Limited | Method of treating a bacterial infection |
US6294199B1 (en) | 1999-04-13 | 2001-09-25 | Beecham Pharmaceuticals (Pte) Limited | Method of treating a bacterial infection comprising administering amoxycillin |
US6878386B1 (en) | 1999-04-13 | 2005-04-12 | Beecham Pharmaceuticals (Pte) Limited | Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate |
GB2365337A (en) * | 1999-04-13 | 2002-02-20 | Beecham Pharma | Amoxycillin and potassium clavulanate high dosage regimen |
EA004310B1 (en) * | 1999-04-13 | 2004-02-26 | Бичам Фармасьютикалз (Пте) Лимитед | Novel method of treatment |
ATE334655T1 (en) * | 1999-08-20 | 2006-08-15 | Glaxosmithkline Lab Sas | PHARMACEUTICAL FORMULATION CONTAINING AMOXICILLIN AND CLAVULANATE |
FR2797588B1 (en) * | 1999-08-20 | 2003-08-01 | Smithkline Beecham Lab | PHARMACEUTICAL FORMULATION BASED ON AMOXYCILLIN AND CLAVULANATE |
SI20411A (en) * | 1999-12-22 | 2001-06-30 | LEK, tovarna farmacevtskih in kemičnih izdelkov, d.d. | Watersoluble powders for peroral solution and their use |
US6756057B2 (en) | 2000-10-12 | 2004-06-29 | Beecham Pharmaceuticals (Pte) Limited | Amoxicillin and potassium clavulanate dosage form |
JP2004519463A (en) * | 2001-01-23 | 2004-07-02 | ガドール エス アー | Composition for prevention and / or treatment of bone metabolic disease, method for preparing the composition and use thereof |
CA2529102A1 (en) * | 2003-06-16 | 2004-12-23 | Glaxo Group Limited | Pharmaceutical formulations comprising amoxicillin and clavulanate |
EP1737449A1 (en) * | 2004-03-01 | 2007-01-03 | LEK Pharmaceuticals D.D. | Pharmaceutical composition |
TR201000687A1 (en) * | 2010-01-29 | 2011-08-22 | Bi̇lgi̇ç Mahmut | Effervescent formulations containing cefixime and clavulanic acid as active ingredient |
TR201000686A1 (en) * | 2010-01-29 | 2011-08-22 | B�Lg�� Mahmut | Water-soluble cefdinir and clavulanic acid formulations for the treatment of bacterial infections. |
WO2013173803A2 (en) * | 2012-05-17 | 2013-11-21 | Michael Spector | Formulations of amoxicillin and clavulanate potassium and methods for using same |
WO2013173808A2 (en) * | 2012-05-17 | 2013-11-21 | Michael Spector | Methods for use of lower dose compositions of amoxicillin and clavulanate potassium and devices for use |
US9254261B2 (en) | 2014-03-03 | 2016-02-09 | Sandoz Ag | Stable quick dissolving dosage form comprising amoxicillin and clavulanic acid |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DZ2028A1 (en) | 1995-05-03 | 2002-10-23 | Smithkline Beecham Plc | Medicines used to treat bacterial infections in pediatrics. |
WO1997006798A2 (en) * | 1995-08-12 | 1997-02-27 | Smithkline Beecham Plc | Pharmaceutical formulations |
AP1253A (en) * | 1997-02-14 | 2004-03-17 | Smithkline Beecham Laboratoires Pharmaceutiques | Pharmaceutical formulations comprising amoxocyllin and clavulanate. |
DE19706978A1 (en) * | 1997-02-21 | 1998-08-27 | Ulrich Dr Posanski | Combination preparation for oral antibiotics |
-
1998
- 1998-07-17 GB GBGB9815532.8A patent/GB9815532D0/en not_active Ceased
-
1999
- 1999-07-15 CZ CZ2001217A patent/CZ296003B6/en not_active IP Right Cessation
- 1999-07-15 RU RU2001102491/14A patent/RU2205639C2/en not_active IP Right Cessation
- 1999-07-15 UA UA2001010380A patent/UA73720C2/en unknown
- 1999-07-15 SK SK84-2001A patent/SK286339B6/en not_active IP Right Cessation
- 1999-07-15 HU HU0103015A patent/HUP0103015A3/en unknown
- 1999-07-15 US US09/743,998 patent/US6511972B1/en not_active Expired - Lifetime
- 1999-07-15 WO PCT/GB1999/002295 patent/WO2000003695A1/en active IP Right Grant
- 1999-07-15 YU YU3101A patent/YU3101A/en unknown
- 1999-07-15 EP EP99934854A patent/EP1098633A1/en not_active Withdrawn
- 1999-07-15 AU AU50497/99A patent/AU762840B2/en not_active Ceased
- 1999-07-15 PL PL99345564A patent/PL194393B1/en not_active IP Right Cessation
-
2001
- 2001-01-17 ZA ZA200100463A patent/ZA200100463B/en unknown
- 2001-01-17 HR HR20000029A patent/HRPK20010048B1/en not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2001102491A (en) | PHARMACEUTICAL SUSPENSION DRUG CONTAINING AMOXICILLINE, CLAVANIC ACID AND CELLULOSE | |
CA2019863C (en) | Aqueous pharmaceutical suspension for substantially water insoluble pharmaceutical actives | |
ES2237121T3 (en) | FAST DISGREGABLE SOLID PREPARATION. | |
JP5202856B2 (en) | Granular solid formulation containing tosfloxacin tosylate | |
JP6092629B2 (en) | Suspension prepared for use with rifaximin | |
KR100979328B1 (en) | Coated particulate cefuroxime axetil compositions | |
JP2016505022A (en) | Honey nose cleaner | |
MXPA03008056A (en) | Taste masked liquid pharmaceutical compositions. | |
JPH0248525B2 (en) | ||
EA001878B1 (en) | Method for treatment of bacterial infection in children | |
RU2205639C2 (en) | Pharmaceutical suspension preparation containing amoxicillin, clavulanic acid and cellulose | |
WO2001026691A1 (en) | Medicinal compositions for oral use | |
JP2002543160A (en) | Pharmaceutical prescription | |
CN101756982B (en) | Artesunate compound medicine composition with improved mouth feeling and high stability | |
JP5799062B2 (en) | Granular solid formulation containing tosufloxacin | |
JP5799061B2 (en) | Granular solid formulation containing tosufloxacin and polyvinylpyrrolidone | |
KR20050109077A (en) | Pharmaceutical composition comprising 5-methyl-2-2'-(chloro-6'-fluoroanilino)phenylacetic acid | |
RU2005138127A (en) | PHARMACEUTICAL PRODUCTS CONTAINING AMOXICILLIN AND CLAVULANATE | |
JP2006522089A (en) | Taste masking vehicle for coated oxazolidinone particles | |
IE902109A1 (en) | Anhydrous oil-based liquid suspension for delivering a¹medicament | |
KR102145022B1 (en) | Suspension composition and dosage form of ibuprofen | |
CN116916892A (en) | Anti-infective dosage forms for the production of nasal washes | |
US20230364038A1 (en) | Anti-infective dosage forms for producing a nasal rinse | |
KR20030027422A (en) | A pharmaceutical composition for taste-making cefuroxime axetil and preparation method of thereof | |
SI20058A (en) | Pharmaceutical forms |